These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38773882)

  • 1. Advances in Nanomaterials for Immunotherapeutic Improvement of Cancer Chemotherapy.
    Liu J; Li B; Li L; Ming X; Xu ZP
    Small; 2024 Sep; 20(38):e2403024. PubMed ID: 38773882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy.
    Le QV; Suh J; Oh YK
    AAPS J; 2019 May; 21(4):64. PubMed ID: 31102154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives.
    Rehan F; Zhang M; Fang J; Greish K
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy.
    Liang C; Zhang Y; Wang S; Jiao W; Guo J; Zhang N; Liu X
    J Mater Chem B; 2024 May; 12(20):4809-4823. PubMed ID: 38695349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Polymeric Nanomedicines for Cancer Immunotherapy.
    Lee ES; Shin JM; Son S; Ko H; Um W; Song SH; Lee JA; Park JH
    Adv Healthc Mater; 2019 Feb; 8(4):e1801320. PubMed ID: 30666822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Membrane Bioconjugation and Membrane-Derived Nanomaterials for Immunotherapy.
    Li PY; Fan Z; Cheng H
    Bioconjug Chem; 2018 Mar; 29(3):624-634. PubMed ID: 29323870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulating Nanomedicine for Cancer Therapy.
    Liu Z; Jiang W; Nam J; Moon JJ; Kim BYS
    Nano Lett; 2018 Nov; 18(11):6655-6659. PubMed ID: 30185039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in nanomaterials for nucleic acid delivery in cancer immunotherapy.
    Mei Y; Wang R; Jiang W; Bo Y; Zhang T; Yu J; Cheng M; Wu Y; Cheng J; Ma W
    Biomater Sci; 2019 Jun; 7(7):2640-2651. PubMed ID: 31090764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of planned cell death of necroptosis in cancer treatment by nanomaterials: Recent advances and future perspectives.
    Sharifi M; Hosseinali SH; Saboury AA; Szegezdi E; Falahati M
    J Control Release; 2019 Apr; 299():121-137. PubMed ID: 30763621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic strategies of iron-based nanomaterials for cancer therapy.
    Wu X; Zhang H
    Biomed Mater; 2021 Mar; 16(3):032003. PubMed ID: 33657014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterials Enhance Pyroptosis-Based Tumor Immunotherapy.
    Ji F; Shi C; Shu Z; Li Z
    Int J Nanomedicine; 2024; 19():5545-5579. PubMed ID: 38882539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon Nanomaterials: Emerging Roles in Immuno-Oncology.
    Patrick B; Akhtar T; Kousar R; Huang CC; Li XG
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-Dimensional Nanomaterials for Photothermal Therapy.
    Liu S; Pan X; Liu H
    Angew Chem Int Ed Engl; 2020 Apr; 59(15):5890-5900. PubMed ID: 32017308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing Cancer Chemo-Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials.
    Wang J; Li L; Xu ZP
    Small Methods; 2024 Jan; 8(1):e2301005. PubMed ID: 37743260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine for T-Cell Mediated Immunotherapy.
    Li F; Ouyang J; Chen Z; Zhou Z; Milon Essola J; Ali B; Wu X; Zhu M; Guo W; Liang XJ
    Adv Mater; 2024 May; 36(22):e2301770. PubMed ID: 36964936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomaterials: Breaking through the bottleneck of tumor immunotherapy.
    Kang Y; Li S
    Int J Biol Macromol; 2023 Mar; 230():123159. PubMed ID: 36610572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of functional nanomedicines for tumor associated macrophages-focused cancer immunotherapy.
    Wei X; Wang J; Liang M; Song M
    Theranostics; 2022; 12(18):7821-7852. PubMed ID: 36451865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomaterials for T-cell cancer immunotherapy.
    Gong N; Sheppard NC; Billingsley MM; June CH; Mitchell MJ
    Nat Nanotechnol; 2021 Jan; 16(1):25-36. PubMed ID: 33437036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances of functional nanomaterials for cancer immunotherapeutic applications.
    Hao Y; Zhou X; Li R; Song Z; Min Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1574. PubMed ID: 31566896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Nanovaccines: Nanomaterials and Clinical Perspectives.
    Desai N; Chavda V; Singh TRR; Thorat ND; Vora LK
    Small; 2024 Aug; 20(35):e2401631. PubMed ID: 38693099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.